A novel paclitaxel-loaded poly(ฮต-caprola
โ
Yangqing Zhang; Lina Tang; Leilei Sun; Junbo Bao; Cunxian Song; Laiqiang Huang;
๐
Article
๐
2010
๐
Elsevier Science
๐
English
โ 562 KB
Multidrug resistance (MDR) of tumor cells is a major obstacle to the success of cancer chemotherapy. Poloxamers have been used in cancer therapy to overcome MDR. The objective of this research is to test the feasibility of paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 (PCL/Poloxamer 188